Back to Results
First PageMeta Content
Microbiology / Infectious diseases / Food safety / Macrolide antibiotics / Bacterial diseases / Tylosin / Campylobacteriosis / Clostridium perfringens / Foodborne illness / Medicine / Health / Biology


Date of Approval: July 30, 2014 FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA[removed]
Add to Reading List

Open Document

File Size: 157,94 KB

Share Result on Facebook

City

Nutreco Canada Agresearch / Harrisonburg / /

Company

Don Whitley Scientific Limited / Lilly / HMS Veterinary Development Inc. / Eli Lilly & Co. / Virginia Diversified Research & Consulting LLC / /

Country

Canada / /

Currency

pence / /

Event

FDA Phase / /

Facility

Laboratory Standard Institute / Co. Lilly Corporate Center / /

IndustryTerm

microbial food safety risks / treatment / treatment of human infectious diseases / edible products / microbial food safety assessment / study site / microbial food safety data / chicken-derived food products / microbial food safety risk assessment / /

MedicalCondition

necrotic enteritis / necrosis / Numerous petechiae / human infectious diseases / induced necrotic enteritis / concurrent necrotic enteritis / coccidiosis / blood clots / Small petechiae / Focal necrosis / necrotic enteritis AND / MS / Severe extensive necrosis / /

Organization

Clinical and Laboratory Standard Institute / US Federal Reserve / FDA / FOOD SAFETY / Test Article Administration / /

Person

Terry TerHune / Michael Sims / Ewen McMillan / Andrew Pridmore / Heather S. Bruce / /

Position

veterinarian / Study Director / GENERAL INFORMATION A. File Number NADA / representative / /

Product

HMS / Lilly Corporate Center Indianapolis / this / g / TYLAN / /

ProvinceOrState

Indiana / Ontario / /

SocialTag